---
{"dg-publish":true,"permalink":"/research/insights/2025-01-29-10-46-32/","tags":["insight"],"created":"2025-12-03T14:34:59.567-05:00","updated":"2025-12-03T14:34:59.567-05:00"}
---

# Content
- Daily intraperitoneal injections of 2.5 mg/kg [[Research/Tags/Urolithin A\|Urolithin A]] in mice reduce pain from chronic [[Research/Tags/Sciatic Nerve\|Sciatic Nerve]] constriction compared to mice not administered urolithin A
# References
<div><table class="dataview table-view-table"><thead class="table-view-thead"><tr class="table-view-tr-header"><th class="table-view-th"><span>Assumptions</span><span class="dataview small-text">1</span></th><th class="table-view-th"><span></span></th></tr></thead><tbody class="table-view-tbody"><tr><td><span><a data-tooltip-position="top" aria-label="Research/Assumptions/2025-01-28 21-11-20.md" data-href="Research/Assumptions/2025-01-28 21-11-20.md" href="Research/Assumptions/2025-01-28 21-11-20.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-28 21-11-20</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="M11 21.73a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16V8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73z"></path><path d="M12 22V12"></path><polyline points="3.29 7 12 12 20.71 7"></polyline><path d="m7.5 4.27 9 5.15"></path></svg></a></span></td><td><span>The behavioral tests used in wangUrolithinAlleviatesNeuropathic2023 are appropriate for assessing pain from constriction of the <a data-href="Sciatic Nerve" href="Sciatic Nerve" class="internal-link" target="_blank" rel="noopener nofollow">Sciatic Nerve</a></span></td></tr></tbody></table></div><div><table class="dataview table-view-table"><thead class="table-view-thead"><tr class="table-view-tr-header"><th class="table-view-th"><span>Insights</span><span class="dataview small-text">1</span></th><th class="table-view-th"><span></span></th></tr></thead><tbody class="table-view-tbody"><tr><td><span><a data-tooltip-position="top" aria-label="Research/Insights/2025-01-29 10-52-06.md" data-href="Research/Insights/2025-01-29 10-52-06.md" href="Research/Insights/2025-01-29 10-52-06.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">2025-01-29 10-52-06</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="M11 21.73a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16V8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73z"></path><path d="M12 22V12"></path><polyline points="3.29 7 12 12 20.71 7"></polyline><path d="m7.5 4.27 9 5.15"></path></svg></a></span></td><td><span>Daily intraperitoneal injections of 2.5 mg/kg <a data-href="Urolithin A" href="Urolithin A" class="internal-link" target="_blank" rel="noopener nofollow">Urolithin A</a> in mice reduce the pain-related behavioral deficits from chronic <a data-href="Sciatic Nerve" href="Sciatic Nerve" class="internal-link" target="_blank" rel="noopener nofollow">Sciatic Nerve</a> constriction compared to mice not administered urolithin A when injections begin immediately after constriction surgery</span></td></tr></tbody></table></div><div><table class="dataview table-view-table"><thead class="table-view-thead"><tr class="table-view-tr-header"><th class="table-view-th"><span>Original Sources</span><span class="dataview small-text">1</span></th><th class="table-view-th"><span>Citations</span></th></tr></thead><tbody class="table-view-tbody"><tr><td><span><a data-tooltip-position="top" aria-label="Research/Evidence Sources/wangUrolithinAlleviatesNeuropathic2023.md" data-href="Research/Evidence Sources/wangUrolithinAlleviatesNeuropathic2023.md" href="Research/Evidence Sources/wangUrolithinAlleviatesNeuropathic2023.md" class="internal-link" target="_blank" rel="noopener nofollow" fileclass-name="Research Links">wangUrolithinAlleviatesNeuropathic2023</a><a class="metadata-menu fileclass-icon"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="svg-icon lucide-package"><path d="M11 21.73a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16V8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73z"></path><path d="M12 22V12"></path><polyline points="3.29 7 12 12 20.71 7"></polyline><path d="m7.5 4.27 9 5.15"></path></svg></a></span></td><td><span>Wang, Chenyi, Zizhu Wang, Shiyu Xue, Yutong Zhu, Jiahao Jin, Qiuyu Ren, and Xiaodong Shi. “Urolithin A Alleviates Neuropathic Pain and Activates Mitophagy.” Molecular Pain 19 (July 28, 2023): 17448069231190815. <a rel="noopener nofollow" class="external-link" href="https://doi.org/10.1177/17448069231190815" target="_blank">https://doi.org/10.1177/17448069231190815</a>.</span></td></tr></tbody></table></div>

# Database Fields